Liminal BioSciences Inc. Common Shares (LMNL)

LMNL was delisted on the 25th of September, 2023.

• Market cap: $27.6M
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Liminal Biosciences Inc is a clinical stage biopharmaceutical company focused on developing distinctive novel small molecule therapeutics for inflammatory, fibrotic, and metabolic diseases using our drug discovery platform and a data driven approach. The company has active business operations in Canada and the United Kingdom.

Employees: 43